• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Suven Life Sciences Limited — Updates, 10-07-2026: Press Release

    10-07-2026 | 12:24 pm

    Suven Life Sciences will present five scientific posters at a global Alzheimer's conference, detailing updates on its Phase-3 Masupirdine study for Alzheimer's Agitation and Phase-2 Usmarapride program for cognitive disorders, alongside other neuroscience pipeline developments.

    No comments yet. Be the first to comment!

    All announcements from Suven Life Sciences Limited